New York, NY, United States of America

Sherry Kan

This inventor holds 1 USPTO granted patent. Top assignee: The Rockefeller University. Active years: 2016.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sherry Kan: Innovator in Recombinant Phages and Proteins

Introduction

Sherry Kan is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant phages and proteins. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing scientific knowledge.

Latest Patents

Sherry Kan holds a patent for recombinant phages and proteins. The present disclosure provides recombinant phages, a Wip1 p23 receptor binding protein, and a Wip1 p24 receptor binding protein that bind to specific targets. The disclosure further provides methods and uses thereof, highlighting the potential applications of her inventions in various fields.

Career Highlights

Sherry Kan is affiliated with The Rockefeller University, where she conducts her research and collaborates with other leading scientists. Her work has garnered attention for its innovative approach and potential impact on biotechnology and medicine.

Collaborations

Throughout her career, Sherry has collaborated with notable scientists such as Vincent A. Fischetti and Raymond Schuch. These collaborations have enriched her research and contributed to the advancement of her projects.

Conclusion

Sherry Kan is a trailblazer in the field of recombinant phages and proteins, with a patent that underscores her innovative contributions. Her work at The Rockefeller University and collaborations with esteemed colleagues further enhance her impact in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…